SCHEMBL3673155

SCHEMBL3673155

CCCCCCNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.48
ANPEP P15144 1/20 0.45
ERAP2 Q6P179 1/20 0.45
ALDH1A1 P00352 2/20 0.43
TSHR P16473 1/20 0.43
LMNA P02545 3/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
TDP1 Q9NUW8 1/20 0.39
CYP2D6 P10635 2/20 0.39
SPHK1 Q9NYA1 1/20 0.39
GMNN O75496 1/20 0.39
POLB P06746 1/20 0.39
THPO P40225 1/20 0.39
MTOR P42345 1/20 0.39
BLM P54132 1/20 0.39
TP53 P04637 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
MAPT P10636 1/20 0.39
CETP P11597 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1665839 1.00 KDM4E (0.48) KDM4EANPEPERAP2ALDH1A1TSHR
SCHEMBL6012839 1.00 KDM4E (0.48) KDM4EANPEPERAP2ALDH1A1TSHR
SCHEMBL14118625 1.00 KDM4E (0.48) KDM4EANPEPERAP2ALDH1A1TSHR
SCHEMBL3801934 1.00 KDM4E (0.48) KDM4EANPEPERAP2ALDH1A1TSHR
SCHEMBL617140 1.00 KDM4E (0.48) KDM4EANPEPERAP2ALDH1A1TSHR
SCHEMBL7275105 1.00 KDM4E (0.48) KDM4EANPEPERAP2ALDH1A1TSHR
SCHEMBL17678369 1.00 KDM4E (0.48) KDM4EANPEPERAP2ALDH1A1TSHR
SCHEMBL12510924 1.00 KDM4E (0.48) KDM4EANPEPERAP2ALDH1A1TSHR
SCHEMBL8433089 1.00 KDM4E (0.48) KDM4EANPEPERAP2ALDH1A1TSHR
SCHEMBL11328260 1.00 KDM4E (0.48) KDM4EANPEPERAP2ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3284809-B1 CLEANING COMPOSITION PROCTER & GAMBLE (US) 2019-09-25 EP claimed
EP-3530723-A1 AUTOMATIC DISHWASHING COMPOSITION The Procter & Gamble Company (US) 2019-08-28 EP claimed
US-20190256802-A1 AUTOMATIC DISHWASHING COMPOSITION THE PROCTER & GAMBLE COMPANY 2019-08-22 US claimed
US-20190055496-A1 METHOD OF CLEANING HOUSEHOLD SURFACES THE PROCTER & GAMBLE COMPANY 2019-02-21 US claimed
EP-3444325-A1 METHOD OF CLEANING HOUSEHOLD SURFACES The Procter & Gamble Company (US) 2019-02-20 EP claimed
WO-2018035191-A1 CLEANING COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 2018-02-22 WO claimed
US-20180051232-A1 CLEANING COMPOSITION THE PROCTER & GAMBLE COMPANY 2018-02-22 US claimed
EP-3284809-A1 CLEANING COMPOSITION The Procter & Gamble Company (US) 2018-02-21 EP claimed
US-20240174675-A1 SMALL MOLECULE REGULATORS OF ALVEOLAR TYPE 2 CELL PROLIFERATION FOR THE TREATMENT OF PULMONARY DISEASES THE SCRIPPS RESEARCH INSTITUTE 2024-05-30 US disclosed
CN-117177958-A Small molecule modulators of alveolar type 2cell proliferation for the treatment of pulmonary diseases 斯克里普斯研究学院 2023-12-05 CN disclosed
EP-4281439-A1 SMALL MOLECULE REGULATORS OF ALVEOLAR TYPE 2 CELL PROLIFERATION FOR THE TREATMENT OF PULMONARY DISEASES The Scripps Research Institute (US) 2023-11-29 EP disclosed
EP-3444325-B1 METHOD OF CLEANING HOUSEHOLD SURFACES PROCTER & GAMBLE (US) 2023-10-04 EP disclosed
WO-2022159955-A1 SMALL MOLECULE REGULATORS OF ALVEOLAR TYPE 2 CELL PROLIFERATION FOR THE TREATMENT OF PULMONARY DISEASES THE SCRIPPS RESEARCH INSTITUTE (US) 2022-07-28 WO disclosed
US-20220008304-A1 MIXED SUGAR COMPOSITIONS PROCTER & GAMBLE (US) 2022-01-13 US disclosed
US-4515811-A POSTPONEMENT OF PARTURITION SYNTEX CORPORATION (PA) 1985-05-07 US disclosed
EP-0095901-A1 Process for the preparation of (d) 2-(d-methoxy-2-naphthyl) propionic acid and pharmaceutically acceptable salts thereof and new intermediates therefor SYNTEX PHARMACEUTICALS INTERNATIONAL LIMITED (BM) 1983-12-07 EP disclosed
EP-0022529-B1 PROCESS FOR THE RESOLUTION OF D,L 2-(6-METHOXY-2-NAPHTHYL)PROPIONIC ACID; A MIXTURE OF THE SALTS OF THESE D AND L ACIDS; A PHARMACEUTICAL COMPOSITION CONTAINING A SALT OF THE D ACID; A SALT OF THE D ACID SYNTEX PHARMACEUTICALS INTERNATIONAL LIMITED (BM) 1983-06-29 EP disclosed
EP-0022529-A1 Process for the resolution of d,l 2-(6-methoxy-2-naphthyl)propionic acid; a mixture of the salts of these d and l acids; a pharmaceutical composition containing a salt of the d acid; a salt of the d acid SYNTEX PHARMACEUTICALS INTERNATIONAL LIMITED (BM) 1981-01-21 EP disclosed
US-4246193-A USING N-ALKYL-D-GLUCAMINE TO FORM A SALT SYNTEX CORPORATION (PA) 1981-01-20 US disclosed
US-4021539-A Skin treating cosmetic compositions containing N-polyhydroxyalkyl-amines HENKEL & CIE G.M.B.H. (DT) 1977-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220008304-A1 MIXED SUGAR COMPOSITIONS MGAM, ABHD6, PHOSPHO1 KDM4E 1841/4885ANPEP 1029/4885ERAP2 3551/4885
US-20240174675-A1 SMALL MOLECULE REGULATORS OF ALVEOLAR TYPE 2 CELL PROLIFERATION FOR THE TREATMENT OF PULMONARY DISEASES DPP4, DPP7, DPP3 KDM4E 2161/4885ANPEP 229/4885ERAP2 486/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.